Literature DB >> 31228039

Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy.

Jessica L Cohen1,2, Elena Thompson3, Liron Sinvani4,3, Andrzej Kozikowski3,5, Guang Qiu4, Renee Pekmezaris3,5, Alex C Spyropoulos3,6, Jason J Wang3,5.   

Abstract

This study evaluates three warfarin dosing algorithms (Kimmel, Dawson, High Dose ≥ 2.5 mg) for hospitalized older adults. A random selection of 250 patients with overshoots (INR ≥ 5 after 48 h of hospitalization) and 250 patients without overshoots were accessed from a database of 12,107 inpatients ≥ 65 years treated with chronic warfarin during hospitalization between January 1, 2014 and June 30, 2016. Algorithms were retrospectively applied to patients 2 days prior to overshoots in the overshoot group, and 2 days prior to the maximum INR reached after 48 h of hospitalization in the non-overshoot group. Patients were categorized as overdosed or not overdosed and compared using descriptive statistics. Logistic regression modeling determined predictors for overshoots. There was no significant difference between overdose and non-overdose groups for progressing to overshoots by the Kimmel (51.0% vs. 48.7%, p = 0.67) or Dawson (48.5 vs. 57.9%, p = 0.19) algorithms. The Low Dose Group (≤ 2.5 mg) was significantly more likely to experience an overshoot than the High Dose Group (56.6% vs. 45.5%, p = 0.04). The Low Dose Group was more likely to be older (81.4% vs. 71.1%, p = 0.02), female (63.5% vs. 49.8%, p = 0.02), weigh less (71.3 ± 21.9 vs. 79 ± 23.1, p = 0.002), and be prescribed amiodarone (16.6% vs. 8.1%, p = 0.01). While none of the algorithms predicted overshoots in logistic regression modeling, weight over 70 kg and black race remained protective. The High Dose Algorithm revealed that providers appropriately gave lower doses to patients at highest risk for warfarin sensitivity. Future studies are needed to investigate tools for inpatient warfarin dosing in older adults.

Entities:  

Keywords:  Dose algorithm; Inpatients; International normalized ratio; Warfarin

Mesh:

Substances:

Year:  2019        PMID: 31228039     DOI: 10.1007/s11239-019-01902-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  15 in total

1.  Inpatient warfarin management: pharmacist management using a detailed dosing protocol.

Authors:  Nancy L Dawson; Ivan E Porter; Dusko Klipa; William R Bamlet; Mary Ann Hedges; Michael J Maniaci; Jason Persoff; Archana Roy; Alden V Patel
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  Dosing guidelines, not protocols, for managing warfarin therapy.

Authors:  Ann K Wittkowsky; Sarah A Spinler; William Dager; Michael P Gulseth; Edith A Nutescu
Journal:  Am J Health Syst Pharm       Date:  2010-09-15       Impact factor: 2.637

3.  Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.

Authors:  Harriette G C Van Spall; Lars Wallentin; Salim Yusuf; John W Eikelboom; Robby Nieuwlaat; Sean Yang; Conrad Kabali; Paul A Reilly; Michael D Ezekowitz; Stuart J Connolly
Journal:  Circulation       Date:  2012-10-01       Impact factor: 29.690

4.  Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance.

Authors:  David C Classen; Lisa Jaser; Daniel S Budnitz
Journal:  Jt Comm J Qual Patient Saf       Date:  2010-01

5.  A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Authors:  Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

Review 6.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

7.  Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy.

Authors:  L Harrison; M Johnston; M P Massicotte; M Crowther; K Moffat; J Hirsh
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

8.  Long-term trends in antithrombotic drug prescriptions among adults aged 80 years and over from primary care: a temporal trends analysis using electronic health records.

Authors:  A Dregan; R Ravindrarajah; J Charlton; M Ashworth; M Molokhia
Journal:  Ann Epidemiol       Date:  2018-03-19       Impact factor: 3.797

9.  Warfarin Quality Metrics for Hospitalized Older Adults.

Authors:  Jessica Cohen; Liron Sinvani; Jason J Wang; Andrzej Kozikowski; Vidhi Patel; Guang Qiu; Renee Pekmezaris; Alex C Spyropoulos
Journal:  TH Open       Date:  2018-07-18

Review 10.  Warfarin initiation nomograms for venous thromboembolism.

Authors:  Pedro Garcia; Wilson Ruiz; César Loza Munárriz
Journal:  Cochrane Database Syst Rev       Date:  2016-01-29
View more
  1 in total

Review 1.  Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications.

Authors:  Yazun Bashir Jarrar; Su-Jun Lee
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.